Medical treatment of constipation
- PMID: 20011345
- PMCID: PMC2780140
- DOI: 10.1055/s-2005-870887
Medical treatment of constipation
Abstract
Various agents are used for the medical management of chronic constipation, but few of these have been adequately studied. This article specifically examines the medical treatment of chronic constipation and the available data concerning bulk agents, lubricating agents, stimulants, and osmotic laxatives, used alone and in combination. Most experts consider dietary fiber or medicinal bulk agents to be the initial therapeutic option for the treatment of chronic constipation. If fiber is not successful or poorly tolerated, subsequent treatments may include saline osmotic laxatives, lactulose, 5-hydroxytryptamine4 (5-HT(4)) agonists (tegaserod), or stimulants such as senna or bisacodyl. Recent data also demonstrate both polyethylene glycol laxative and tegaserod to be safe and effective as initial therapy for chronic constipation.
Keywords: 5-HT4 agonists; Constipation; fiber; laxatives; osmotic agents; polyethylene glycol.
References
-
- Di Palma J A. Current treatment options for chronic constipation. Rev Gastroenterol Disord. 2004;4:S34–S42. - PubMed
-
- Meshkinpour H, Selod S, Movahedi H, et al. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci. 1998;43:2379–2383. - PubMed
-
- Young R J, Beerman L E, Vanderhoff J A. Increasing oral fluids in chronic constipation in children. Gastroenterol Nurs. 1998;21:156–161. - PubMed
-
- Madoff R D, Fleshman J W. AGA technical review on the diagnosis and care of patients with anal fissure. Gastroenterology. 2003;124:235–245. - PubMed
-
- Locke G R, III, Pemberton J H, Phillips S F. AGA Medical Position Statement: guidelines on constipation. Gastroenterology. 2000;119:1761–1778. - PubMed
LinkOut - more resources
Full Text Sources